Product Information

SUTAB TABLET is a brand product labeled by Braintree Laboratories, Inc., priced at $6.7240 per EA under NDC 52268020101. Its NADAC has been published 297 times since Mar 17, 2021.

FDA first approved this application on Nov 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

Strength

2.7; 2.25; 17.75 g/1; g/1; g/1

NDC

52268020101

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA213135

FDA Approved

11/10/2020

TE Code

AB

On Market Since

11/10/2020

Pharmacological Classes

Calculi Dissolution Agent
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Small Intestine Fluid/Electrolyte Absorption
Magnesium Ion Exchange Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price Statistics

The NADAC for SUTAB TABLET has been published 297 times since Mar 17, 2021, and over the history we have for it it has risen 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$6.7240 per EA
All-time high$6.7483 (May 14, 2025)
All-time low$5.9751 (Mar 17, 2021)
52-week high$6.7428
52-week low$6.7203
Median price$6.5431
Average price$6.4335
Largest weekly change+3.0% (Jan 11, 2023)
Weeks tracked297
Tracking sinceMar 17, 2021

Price History

1W

+0.1%

1M

-0.2%

3M

-0.2%

6M

-0.3%

1Y

-0.1%

3Y

+5.8%

5Y

+12.5%

All

+12.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sodium sulfate, magnesium sulfate, and potassium chloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUTAB TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SUTAB TABLET, manufactured by Braintree Laboratories, Inc., is $6.7240 per EA (NDC 52268020101), effective Nov 18, 2026.

How has the price of SUTAB TABLET changed over time?

Over the history we have for it, the NADAC for SUTAB TABLET has risen 12.5%. It has been tracked across 297 weekly CMS publications since Mar 17, 2021.

What are the highest and lowest recorded NADAC prices for SUTAB TABLET?

Since Mar 17, 2021, the NADAC for SUTAB TABLET has ranged from a low of $5.9751 (Mar 17, 2021) to a high of $6.7483 (May 14, 2025), with a median of $6.5431 per EA.

Are there cheaper alternatives to SUTAB TABLET?

No other NADAC-published product currently shares the active ingredient and strength of SUTAB TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SUTAB TABLET?

SUTAB TABLET (NDC 52268020101) is labeled by Braintree Laboratories, Inc., and CMS classifies it as a brand product.